Skip to main content

Table 2 Clinical characteristics and their association with CAT use

From: Use of complementary and alternative therapies by patients with eye diseases: a hospital-based cross-sectional study from Palestine

Variable Overall
N = 86 (%)
CAT users N = 58 (%) Non-CAT users
N = 28 (%)
P-value
Diagnosis     0.712 a
 Corneal disease 14 (16.3) 9 (15.5) 5 (17.9)  
 Lens disease 30 (34.9) 22 (37.9) 8 (28.6)  
 Retinal disease 31 (36.0) 21 (36.2) 10 (35.7)  
 Others 11 (12.8) 6 (10.3) 5 (17.9)  
Symmetry of eye disease     0.006a
 Unilateral 40 (46.5) 21 (36.2) 19 (67.9)  
 Bilateral 46 (53.5) 37 (63.8) 9 (32.1)  
Chronicity of disease     0.135 a
 Acute 22 (25.6) 12 (20.7) 10 (35.7)  
 Chronic 64 (74.4) 46 (79.3) 18 (64.3)  
Route of treatment     
 Topical 67 (77.9) 43 (74.1) 24 (85.7) 0.277 b
 Systemic 9 (10.5) 7 (12.1) 2 (7.1) 0.712 b
 Intra-ocular injections 18 (20.9) 15 (25.9) 3 (10.7) 0.157 b
 Surgical 48 (55.8) 28 (48.3) 20 (71.4) 0.043 a
Ocular co-morbidities     0.695 a
 Absent 59 (68.6) 39 (67.2) 20 (71.4)  
 Present 27 (31.4) 19 (32.8) 8 (28.6)  
  1. a Statistical significance value calculated using Chi-Square
  2. b Statistical significance value calculated using Fisher’s exact test